Synergistic Effects of Caffeine in Combination with Conventional Drugs: Perspectives of a Drug That Never Ages

Plants have been known since ancient times for their healing properties, being used as preparations against human diseases of different etiologies. More recently, natural products have been studied and characterized, isolating the phytochemicals responsible for their bioactivity. Most certainly, there are currently numerous active compounds extracted from plants and used as drugs, dietary supplements, or sources of bioactive molecules that are useful in modern drug discovery. Furthermore, phytotherapeutics can modulate the clinical effects of co-administered conventional drugs. In the last few decades, the interest has increased even more in studying the positive synergistic effects between plant-derived bioactives and conventional drugs. Indeed, synergism is a process where multiple compounds act together to exert a merged effect that is greater than that of each of them summed together. The synergistic effects between phytotherapeutics and conventional drugs have been described in different therapeutic areas, and many drugs are based on synergistic interactions with plant derivatives. Among them, caffeine has shown positive synergistic effects with different conventional drugs. Indeed, in addition to their multiple pharmacological activities, a growing body of evidence highlights the synergistic effects of caffeine with different conventional drugs in various therapeutic fields. This review aims to provide an overview of the synergistic therapeutic effects of caffeine and conventional drugs, summarizing the progress reported to date.

[1]  J. Piosik,et al.  New Life of an Old Drug: Caffeine as a Modulator of Antibacterial Activity of Commonly Used Antibiotics , 2022, Pharmaceuticals.

[2]  K. Dzobo,et al.  The Role of Natural Products as Sources of Therapeutic Agents for Innovative Drug Discovery , 2021, Reference Module in Biomedical Sciences.

[3]  M. Aboutabl,et al.  Simultaneous administration of coffee and rasagiline/l-dopa protects against paraquat-induced neurochemical and motor behavior impairments in vivo , 2021, Bulletin of the National Research Centre.

[4]  Giuseppe Faudone,et al.  The Medicinal Chemistry of Caffeine. , 2021, Journal of medicinal chemistry.

[5]  A. Alshabi,et al.  Caffeine modulates pharmacokinetic and pharmacodynamic profiles of pioglitazone in diabetic rats , 2021, Saudi medical journal.

[6]  M. Morelli,et al.  Protective Agents in Parkinson’s Disease: Caffeine and Adenosine A2A Receptor Antagonists , 2021, Handbook of Neurotoxicity.

[7]  M. Diaz,et al.  PLANT EXTRACTS DISPLAY SYNERGISM WITH DIFFERENT CLASSES OF ANTIBIOTICS , 2021, Biologia: Ensino, Pesquisa e Extensão - Uma Abordagem do Conhecimento Científico nas Diferentes Esferas do Saber.

[8]  M. Kim,et al.  Antioxidant and Neuroprotective Effects of Caffeine against Alzheimer’s and Parkinson’s Disease: Insight into the Role of Nrf-2 and A2AR Signaling , 2020, Antioxidants.

[9]  C. Bai,et al.  The Effect of Caffeine on the Risk and Progression of Parkinson’s Disease: A Meta-Analysis , 2020, Nutrients.

[10]  K. Jacobson,et al.  Adenosine A2A receptor antagonists: from caffeine to selective non‐xanthines , 2020, British journal of pharmacology.

[11]  Zhilei Wang,et al.  Caffeine enhances the anti-tumor effect of 5-fluorouracil via increasing the production of reactive oxygen species in hepatocellular carcinoma , 2019, Medical Oncology.

[12]  P. Sengupta,et al.  Edaravone-caffeine combination for the effective management of rotenone induced Parkinson’s disease in rats: An evidence based affirmative from a comparative analysis of behavior and biomarker expression , 2019, Neuroscience Letters.

[13]  N. Yamamoto,et al.  Caffeine citrate enhanced cisplatin antitumor effects in osteosarcoma and fibrosarcoma in vitro and in vivo , 2019, BMC Cancer.

[14]  Priscilla A DA Costa,et al.  Plant Extracts Display Synergism with Different Classes of Antibiotics. , 2019, Anais da Academia Brasileira de Ciencias.

[15]  B. Salehi,et al.  Synergistic Effects of Plant Derivatives and Conventional Chemotherapeutic Agents: An Update on the Cancer Perspective , 2019, Medicina.

[16]  T. Weiser,et al.  Effect of Caffeine on the Bioavailability and Pharmacokinetics of an Acetylsalicylic Acid-Paracetamol Combination: Results of a Phase I Study , 2019, Advances in Therapy.

[17]  P. Agostinho,et al.  Blockade of adenosine A2A receptors recovers early deficits of memory and plasticity in the triple transgenic mouse model of Alzheimer's disease , 2018, Neurobiology of Disease.

[18]  I. Gordo,et al.  Evolutionary Mechanisms Shaping the Maintenance of Antibiotic Resistance. , 2018, Trends in microbiology.

[19]  S. Antollini,et al.  A novel pharmacological activity of caffeine in the cholinergic system , 2018, Neuropharmacology.

[20]  D. Miljkovic,et al.  Caffeine induces metformin anticancer effect on fibrosarcoma in hamsters. , 2018, European review for medical and pharmacological sciences.

[21]  A. Nehlig Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption , 2018, Pharmacological Reviews.

[22]  R. Cunha,et al.  Chronic coffee consumption and respiratory disease: A systematic review , 2018, The clinical respiratory journal.

[23]  M. Hidaka,et al.  Caffeine Has a Synergistic Anticancer Effect with Cisplatin via Inhibiting Fanconi Anemia Group D2 Protein Monoubiquitination in Hepatocellular Carcinoma Cells. , 2017, Biological & pharmaceutical bulletin.

[24]  R. Lipton,et al.  Caffeine in the management of patients with headache , 2017, The Journal of Headache and Pain.

[25]  Richard E. Harris,et al.  Caffeine as an opioid analgesic adjuvant in fibromyalgia , 2017, Journal of pain research.

[26]  V. Giaccone,et al.  Antimicrobial resistance: A global emerging threat to public health systems , 2017, Critical reviews in food science and nutrition.

[27]  Julie Brown,et al.  Antenatal Corticosteroids for Accelerating Fetal Lung Maturation for Women at Risk of Preterm Birth , 2007, The Cochrane database of systematic reviews.

[28]  N. Yamamoto,et al.  Non-toxic Efficacy of the Combination of Caffeine and Valproic Acid on Human Osteosarcoma Cells In Vitro and in Orthotopic Nude-mouse Models. , 2016, Anticancer research.

[29]  M. Gharghabi,et al.  The Effect of Caffeine and chk2 Inhibitor on Doxorubicin-Induced Cellular Senescence in MCF-7 Cells , 2016, Drug Research.

[30]  Andrew P. Smith,et al.  Caffeine: Friend or Foe? , 2016, Annual review of food science and technology.

[31]  L. Price,et al.  Animal production and antimicrobial resistance in the clinic , 2016, The Lancet.

[32]  E. Eichenwald Apnea of Prematurity , 2016, Pediatrics.

[33]  A. Al-majed,et al.  Chapter Five – Pioglitazone , 2016 .

[34]  R. D'Hooge,et al.  A2A adenosine receptor deletion is protective in a mouse model of Tauopathy , 2016, Molecular Psychiatry.

[35]  M. Diederich,et al.  Coffee provides a natural multitarget pharmacopeia against the hallmarks of cancer , 2015, Genes & Nutrition.

[36]  F. Greenway,et al.  The effect of caffeine and albuterol on body composition and metabolic rate , 2015, Obesity.

[37]  Michael Wink,et al.  Modes of Action of Herbal Medicines and Plant Secondary Metabolites , 2015, Medicines.

[38]  S. Bruno,et al.  Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells , 2015, Oncotarget.

[39]  J. Haber,et al.  Caffeine inhibits gene conversion by displacing Rad51 from ssDNA , 2015, Nucleic acids research.

[40]  Mickael Guedj,et al.  Analysis of drug combinations: current methodological landscape , 2015, Pharmacology research & perspectives.

[41]  T. Miyazaki,et al.  Development of tumor-specific caffeine-potentiated chemotherapy using a novel drug delivery system with Span 80 nano-vesicles , 2015, Oncology reports.

[42]  U. Kadam,et al.  Multi-drug therapy in chronic condition multimorbidity: a systematic review. , 2014, Family practice.

[43]  E. Poleszak,et al.  Review on analgesic effect of co-administrated ibuprofen and caffeine , 2014 .

[44]  M. Kamal,et al.  Hepatoprotective Effects of Silybum marianum (Silymarin) and Glycyrrhiza glabra (Glycyrrhizin) in Combination: A Possible Synergy , 2014, Evidence-based complementary and alternative medicine : eCAM.

[45]  R. Kazmierkiewicz,et al.  Caffeine and other methylxanthines as interceptors of food-borne aromatic mutagens: inhibition of Trp-P-1 and Trp-P-2 mutagenic activity. , 2013, Chemical research in toxicology.

[46]  Y. Okamura,et al.  Evaluation of anticancer effects and enhanced doxorubicin cytotoxicity of xanthine derivatives using canine hemangiosarcoma cell lines. , 2013, Research in veterinary science.

[47]  S. Oh,et al.  Caffeine as an adjuvant therapy to opioids in cancer pain: a randomized, double-blind, placebo-controlled trial. , 2013, Journal of pain and symptom management.

[48]  J. Piosik,et al.  Modulation of acridine mutagen ICR191 intercalation to DNA by methylxanthines--analysis with mathematical models. , 2013, Bioorganic & medicinal chemistry.

[49]  M. I. Díaz-Reval,et al.  Opioid Mechanism Involvement in the Synergism Produced by the Combination of Diclofenac and Caffeine in the Formalin Model , 2013, ISRN Pain.

[50]  B. Kramer,et al.  Synergistic Effect of Caffeine and Glucocorticoids on Expression of Surfactant Protein B (SP-B) mRNA , 2012, PloS one.

[51]  O. Obodozie Pharmacokinetics and Drug Interactions of Herbal Medicines: A Missing Critical Step in the Phytomedicine/Drug Development Process , 2012 .

[52]  Shwu-Huey Liu,et al.  Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy. , 2012, Journal of ethnopharmacology.

[53]  Tina Manzhu Kang,et al.  The Aminoglycoside Antibiotic Kanamycin Damages DNA Bases in Escherichia coli: Caffeine Potentiates the DNA-Damaging Effects of Kanamycin while Suppressing Cell Killing by Ciprofloxacin in Escherichia coli and Bacillus anthracis , 2012, Antimicrobial Agents and Chemotherapy.

[54]  David J Newman,et al.  Natural products as sources of new drugs over the 30 years from 1981 to 2010. , 2012, Journal of natural products.

[55]  A. Izzo Interactions between Herbs and Conventional Drugs: Overview of the Clinical Data , 2012, Medical Principles and Practice.

[56]  D. M. Robinson,et al.  Pioglitazone , 2012, Drugs.

[57]  A. Bode,et al.  Coffee phenolic phytochemicals suppress colon cancer metastasis by targeting MEK and TOPK. , 2011, Carcinogenesis.

[58]  K. Audenaert,et al.  Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine's Protective Effect against Alzheimer's Disease , 2011, International journal of Alzheimer's disease.

[59]  J. Sawynok Caffeine and pain , 2011, PAIN®.

[60]  H. Ke,et al.  Inhibition of cyclic nucleotide phosphodiesterases by methylxanthines and related compounds. , 2011, Handbook of experimental pharmacology.

[61]  David J Henderson-Smart,et al.  Methylxanthine treatment for apnoea in preterm infants. , 2010, The Cochrane database of systematic reviews.

[62]  M. González-Trujano,et al.  Tramadol and caffeine produce synergistic interactions on antinociception measured in a formalin model , 2010, Pharmacology Biochemistry and Behavior.

[63]  Y. Hwang,et al.  Metformin blocks migration and invasion of tumour cells by inhibition of matrix metalloproteinase‐9 activation through a calcium and protein kinase Cα‐dependent pathway: phorbol‐12‐myristate‐13‐acetate‐induced/extracellular signal‐regulated kinase/activator protein‐1 , 2010, British journal of pharmacology.

[64]  R. Holley,et al.  Use of natural antimicrobials to increase antibiotic susceptibility of drug resistant bacteria. , 2010, International journal of food microbiology.

[65]  D. Newman,et al.  Impact of natural products on developing new anti-cancer agents. , 2009, Chemical reviews.

[66]  V. Echeverria,et al.  Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice. , 2009, Journal of Alzheimer's disease : JAD.

[67]  M. Wink Evolutionary advantage and molecular modes of action of multi-component mixtures used in phytomedicine. , 2008, Current drug metabolism.

[68]  M. Doble,et al.  Synergism between natural products and antibiotics against infectious diseases. , 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[69]  Chukwuma O. Agubata,et al.  In vitro interaction between caffeine and some penicillin antibiotics against Staphylococcus aureus , 2008 .

[70]  B. Schmidt,et al.  Evidence-Based Neonatal Drug Therapy for Prevention of Bronchopulmonary Dysplasia in Very-Low-Birth-Weight Infants , 2008, Neonatology.

[71]  Masami Kawahara,et al.  The antitumor effect of liposome-encapsulated cisplatin on rat osteosarcoma and its enhancement by caffeine. , 2008, Anticancer research.

[72]  G. Castañeda-Hernández,et al.  Examination of the interaction between peripheral lumiracoxib and opioids on the 1% formalin test in rats , 2008, European journal of pain.

[73]  F. López-Muñoz,et al.  Sinergismo de la cafeína sobre los efectos antinociceptivos del metamizol , 2008 .

[74]  R. Shapiro Caffeine and headaches , 2008, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology.

[75]  A. Nissinen,et al.  Coffee consumption is inversely associated with cognitive decline in elderly European men: the FINE Study , 2007, European Journal of Clinical Nutrition.

[76]  D. Souza,et al.  Caffeine and adenosine A2a receptor antagonists prevent β-amyloid (25–35)-induced cognitive deficits in mice , 2007, Experimental Neurology.

[77]  L. Zacharia,et al.  Caffeine protects Alzheimer’s mice against cognitive impairment and reduces brain β-amyloid production , 2006, Neuroscience.

[78]  Ted Powers,et al.  Caffeine Targets TOR Complex I and Provides Evidence for a Regulatory Link between the FRB and Kinase Domains of Tor1p* , 2006, Journal of Biological Chemistry.

[79]  P. Imming,et al.  Drugs, their targets and the nature and number of drug targets , 2006, Nature Reviews Drug Discovery.

[80]  L. D. Di Stasi,et al.  Synergism between plant extract and antimicrobial drugs used on Staphylococcus aureus diseases. , 2006, Memorias do Instituto Oswaldo Cruz.

[81]  Jesper Bo Nielsen,et al.  Interactions of skin thickness and physicochemical properties of test compounds in percutaneous penetration studies , 2006, International archives of occupational and environmental health.

[82]  S. Ibrahim,et al.  Application of caffeine, 1,3,7-trimethylxanthine, to control Escherichia coli O157:H7 , 2006 .

[83]  H. Diener,et al.  The Fixed Combination of Acetylsalicylic acid, Paracetamol and Caffeine is more Effective than Single Substances and Dual Combination for the Treatment of Headache: a Multicentre, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Parallel Group Study , 2005, Cephalalgia : an international journal of headache.

[84]  J. Piosik,et al.  Formation of stacking complexes between caffeine (1,2,3-trimethylxanthine) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine may attenuate biological effects of this neurotoxin. , 2005, Bioorganic chemistry.

[85]  J. Grutsch,et al.  The use of dietary supplements in a community hospital comprehensive cancer center: implications for conventional cancer care , 2005, Supportive Care in Cancer.

[86]  E. Bastia,et al.  Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinson's disease. , 2005, Pharmacology & therapeutics.

[87]  Weiya Ma,et al.  Caffeine inhibits cell proliferation by G0/G1 phase arrest in JB6 cells. , 2004, Cancer research.

[88]  D. Shi,et al.  Caffeine Analogs: Effects on Ryanodine-Sensitive Calcium-Release Channels and GABAA Receptors , 2003, Cellular and Molecular Neurobiology.

[89]  T. Aburjai,et al.  Screening of antibiotic resistant inhibitors from local plant materials against two different strains of Staphylococcus aureus. , 2002, Journal of ethnopharmacology.

[90]  F. Greenway The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent , 2001, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[91]  S. Mercadante,et al.  Effects of caffeine as an adjuvant to morphine in advanced cancer patients. A randomized, double-blind, placebo-controlled, crossover study. , 2001, Journal of pain and symptom management.

[92]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[93]  A. Nahrstedt,et al.  Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test. , 2000, Planta medica.

[94]  G. G. Nascimento,et al.  Antibacterial activity of plant extracts and phytochemicals on antibiotic-resistant bacteria , 2000 .

[95]  F. Sarkar,et al.  Molecular effects of taxol and caffeine on pancreatic cancer cells. , 1999, International journal of molecular medicine.

[96]  G. Castañeda-Hernández,et al.  A review of the pharmacokinetic and pharmacodynamic factors in the potentiation of the antinociceptive effect of nonsteroidal anti-inflammatory drugs by caffeine. , 1999, Journal of pharmacological and toxicological methods.

[97]  S. Amin,et al.  Inhibition of lung carcinogenesis by black tea in Fischer rats treated with a tobacco-specific carcinogen: caffeine as an important constituent. , 1998, Cancer research.

[98]  N. Yamamoto,et al.  Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma. , 1998, Anticancer research.

[99]  J. Sawynok Adenosine receptor activation and nociception. , 1998, European journal of pharmacology.

[100]  G. Engelhardt,et al.  Role of caffeine in combined analgesic drugs from the point of view of experimental pharmacology. , 1997, Arzneimittel-Forschung.

[101]  J. Sawynok,et al.  Caffeine antinociception: role of formalin concentration and adenosine A1 and A2 receptors. , 1996, European journal of pharmacology.

[102]  F. López-Muñoz,et al.  Potentiation by caffeine of the analgesic effect of aspirin in the pain-induced functional impairment model in the rat. , 1994, Canadian journal of physiology and pharmacology.

[103]  V. Anttila,et al.  Hepatosplenic yeast infection in patients with acute leukemia: a diagnostic problem. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[104]  V. Granados-Soto,et al.  Characterization of the Analgesic Effects of Paracetamol and Caffeine Combinations in the Pain‐induced Functional Impairment Model in the Rat , 1993, The Journal of pharmacy and pharmacology.

[105]  T. Yaksh,et al.  Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. , 1993, Pharmacological reviews.

[106]  G. Pöch Synergism/potentiation and antagonism — phenomena and mechanisms , 1993 .

[107]  Dr. Gerald Pöch Combined Effects of Drugs and Toxic Agents , 1993, Springer Vienna.

[108]  P. Pandhi,et al.  Determination of the optimal analgesia-potentiating dose of caffeine and a study of its effect on the pharmacokinetics of aspirin in mice. , 1991, Methods and findings in experimental and clinical pharmacology.

[109]  Clara Franzini-Armstrong,et al.  The brain ryanodine receptor: A caffeine-sensitive calcium release channel , 1991, Neuron.

[110]  S. Toubro,et al.  Thermogenic synergism between ephedrine and caffeine in healthy volunteers: a double-blind, placebo-controlled study. , 1991, Metabolism: clinical and experimental.

[111]  T. Shimamura,et al.  [Antifungal and fungicidal activities of tea extract and catechin against Trichophyton]. , 1991, Nihon saikingaku zasshi. Japanese journal of bacteriology.

[112]  H. Tsuchiya,et al.  Enhancement of cytocidal and antitumor effect of cisplatin by caffeine in human osteosarcoma. , 1989, Clinical therapeutics.

[113]  M. Berenbaum What is synergy? , 1989, Pharmacological reviews.

[114]  A. Misra,et al.  Potentiation of morphine analgesia by caffeine , 1985, British journal of pharmacology.

[115]  Roberts Jj Mechanism of potentiation by caffeine of genotoxic damage induced by physical and chemical agents. , 1984 .

[116]  R. S. Da Silva,et al.  Caffeine , 1984, Springer Berlin Heidelberg.

[117]  Daniel M. Togasaki,et al.  Caffeine stimulates β-endorphin release in blood but not in cerebrospinal fluid , 1982 .

[118]  K Fuxe,et al.  Effects of caffeine on central monoamine neurons , 1972, The Journal of pharmacy and pharmacology.

[119]  B A Berkowitz,et al.  Release of norepinephrine in the central nervous system by theophylline and caffeine. , 1970, European journal of pharmacology.

[120]  H VELDSTRA,et al.  Synergism and potentiation with special reference to the combination of structural analogues. , 1956, Pharmacological reviews.